TB-500 Capsules contain thymosin beta-related research material in a standardized capsule format for controlled laboratory analysis.
For laboratory research use only. Not for human or animal consumption.
Technical Specifications
| Specification | Product Information |
|---|---|
| Product Name | TB-500 Capsules |
| Research Material | Thymosin beta-related peptide material |
| Format | Encapsulated powder |
| Unit Quantity | Refer to the product label for capsule count and total material per unit |
| Reference Molecular Formula | C₂₁₂H₃₅₀N₅₆O₇₈S for thymosin beta-4; verify the batch-specific material on the COA |
| Reference Molecular Weight | Approximately 4,963 g/mol for thymosin beta-4; verify the batch-specific value on the COA |
| CAS Number | Refer to the batch-specific COA |
| Reference Sequence | Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES-OH |
| Purity | Batch-specific; refer to the applicable Certificate of Analysis |
| Analytical Documentation | Lot-level documentation may include HPLC, mass spectrometry, or other analytical methods where specified |
| Storage Conditions | Store sealed in a cool, dry environment away from direct light, heat, and moisture. Follow the conditions stated on the product label and COA. |
| Intended Classification | Laboratory research material only |
The reference formula, molecular weight, and sequence describe thymosin beta-4 and should be evaluated against the identity stated in the applicable batch documentation.
TB-500 Capsules are sold exclusively for analytical, laboratory, and controlled research purposes. This product is not a drug, dietary supplement, food, cosmetic, or medical product. It is not intended for diagnostic, therapeutic, clinical, veterinary, or household applications.
No dosing, administration, preparation, or application instructions are provided.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
TB-500 Capsules contain thymosin beta-related research material in a standardized capsule format. This product is supplied exclusively for controlled laboratory analysis, compound characterization, formulation assessment, and other legitimate research activities.
Thymosin beta-4 is a 43-amino-acid peptide documented in biochemical literature for its interaction with actin monomers. This molecular relationship has made thymosin beta-related materials relevant to controlled investigations involving peptide-actin binding, actin polymerization, cytoskeletal organization, and peptide structure-function relationships.
The capsule presentation may also be evaluated in research involving unit-to-unit consistency, encapsulated powder characterization, material identity verification, chromatographic profiling, mass-spectrometric analysis, storage-condition comparisons, and stability-indicating analytical methods.
For laboratory research use only. Not for human or animal consumption.
TB-500 Capsule Research Specifications:
| Product Name | TB-500 Capsules |
| Research Material | Thymosin beta-related peptide material |
| Format | Encapsulated powder |
| Unit Quantity | Refer to the product label for capsule count and total material per unit |
| Reference Molecular Formula | C212H350N56O78S for thymosin beta-4; verify the batch-specific material on the applicable Certificate of Analysis |
| Reference Molecular Weight | Approximately 4,963 g/mol for thymosin beta-4; verify the batch-specific value on the applicable Certificate of Analysis |
| CAS Number | Refer to the batch-specific Certificate of Analysis |
| Reference Sequence | Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES-OH |
| Purity / Testing | Batch-specific analytical findings are documented on the applicable Certificate of Analysis |
| Analytical Documentation | Lot-level documentation may include HPLC, mass spectrometry, or other analytical methods where specified |
| Storage Conditions | Store sealed in a cool, dry environment away from direct light, heat, and moisture. Follow the conditions stated on the product label and Certificate of Analysis. |
| Research Use Only | Not for human consumption, animal consumption, clinical procedures, veterinary procedures, diagnostic use, or therapeutic use |
TB-500 Capsules are a research-format presentation of thymosin beta-related peptide material. Laboratories may evaluate the product through analytical characterization, reference comparison, formulation assessment, or controlled in vitro research.
Thymosin beta-4 is described in biochemical literature as an actin-binding peptide. Published laboratory research has examined its interaction with G-actin, the stoichiometry of peptide-actin complexes, and its relationship to actin polymerization under controlled conditions. These observations provide a biochemical framework for research involving molecular binding and cytoskeletal assay systems.
The capsule format introduces formulation variables that may be relevant to analytical study design. Researchers may examine capsule uniformity, powder characteristics, excipient interactions, storage stability, material identification, or differences between encapsulated and non-encapsulated research formats.
Any molecular formula, molecular weight, sequence, salt form, counterion, purity value, or analytical result used in a protocol should be verified against the documentation issued for the applicable product lot.
Important Research Notice: Third-party analytical documentation is available for qualifying lots where applicable. Certificates of Analysis may contain identity, purity, and method-specific findings for laboratory documentation and traceability.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE OR CONDITION.
TB-500 may be incorporated into controlled in vitro assays examining peptide-actin interactions, actin monomer binding, polymerization variables, or cytoskeletal organization. Study designs should use predefined endpoints, validated analytical methods, and appropriate positive, negative, and vehicle controls.
This research context does not establish clinical utility or suitability for use in humans or animals.
Laboratories investigating biochemical signaling networks may include thymosin beta-related material as an experimental variable in controlled assay systems. Appropriate endpoints may include predefined molecular markers, binding measurements, gene-expression data, microscopy findings, or other validated laboratory readouts.
References to biological pathways describe research topics only. They do not establish a medical purpose or approved application for this product.
Comparative laboratory studies may evaluate TB-500 material across different formulations, storage conditions, analytical platforms, or experimental concentrations. Capsule and non-capsule materials should be assessed independently because excipients, preparation procedures, and physical presentation can influence analytical results.
Researchers conducting comparative studies should document:
This section addresses laboratory comparison methodology only. It does not provide guidance for human or animal use.
Research teams examining complex signaling systems may measure multiple biochemical variables within the same controlled experiment. Any investigation involving thymosin beta-related material should remain limited to legitimate laboratory models with clearly defined endpoints, suitable controls, and validated analytical procedures.
The inclusion of immune, cellular, or age-associated markers in an experiment does not establish a consumer benefit, medical purpose, or approved application for TB-500 Capsules.
A Certificate of Analysis provides batch-specific information for laboratory review and traceability. Depending on the qualifying lot, documentation may include:
Researchers should verify that the lot number shown on the product corresponds with the lot number listed on the Certificate of Analysis. Analytical findings should not be generalized across separate batches without lot-specific documentation.
Certificate of Analysis availability does not convert the product into an approved drug, dietary supplement, food, cosmetic, diagnostic material, or therapeutic product.
TB-500 Capsules should be sourced only for legitimate laboratory research. Procurement teams should evaluate product labeling, lot traceability, batch-specific documentation, storage requirements, and institutional restrictions before completing a purchase.
Upon receipt, laboratories should record the lot number, inspect the packaging, review the applicable Certificate of Analysis, and store the product according to the stated conditions. Access should be restricted to trained personnel operating under established laboratory procedures.
IMPORTANT: TB-500 Capsules are sold exclusively for laboratory research. They are not for human or animal consumption and may not be used in clinical, veterinary, diagnostic, therapeutic, food, cosmetic, or supplement applications. Purchasers are responsible for complying with applicable laws, institutional policies, and laboratory requirements.
